LLY News and Press, Eli Lilly and Company From 06/25/24

Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria PR Newswire INDIANAPOLIS , June 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced a collaboration with OpenAI that will allow Lilly to leverage OpenAI's...

2024-06-25 06:30:00 ET Summary Six years ago, Apple became a $1 trillion company, not long before oil titan Saudi Aramco publicly debuted with a 13-digit market capitalization. Chipmaker Broadcom is riding an artificial intelligence wave. Eli Lilly is also on its way, thanks to th...

2024-06-24 15:56:56 ET Here's why Fundstrat's Tom Lee says the S&P 500 may reach 15,000 by 2030 ' Inflation is not the only risk we face', says Fed's Mary Daly The Fed could be running the risk of delaying cuts too long - Pantheon Macroeconomics S&P 500 E...

2024-06-24 15:17:13 ET More on Inspire Medical, ResMed Inspire Medical Systems: A Post Q1 Assessment ResMed, Philips under pressure as Eli Lilly seeks sleep indication for weight loss drug Inspire Medical Systems, Inc. (INSP) Q1 2024 Earnings Call Transcript ...

2024-06-24 14:51:58 ET More on Novo Nordisk Novo Nordisk: Leading The Fight Against Diabetes And Obesity Novo Nordisk: The Market Is Right, Don't Fight Against It Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study Lilly, Novo Nordisk to d...

2024-06-24 13:05:06 ET Summary Zealand Pharma A/S petrelintide showed promising results in a phase 1b study, with patients achieving up to 8.6% weight loss over 16 weeks at the highest dose. The global obesity market could reach $77 billion in 2030. Survodutide, dapiglutide, a...

Eli Lilly and Company (NYSE: LLY) is one of today's top gainers. The company's shares have moved 1.95% on the day to $901.08. Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Hu...

Lilly Declares Third-Quarter 2024 Dividend PR Newswire INDIANAPOLIS , June 24, 2024 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2024 of $1.30 per share on outstanding common stoc...

2024-06-24 11:14:09 ET This week marks the last handful of trading days for H1 2024, as market participants watched so far this year the benchmark S&P 500 ( SP500 ) advance 15.1% year to date.... Read the full article on Seeking Alpha For further details see: Top...

2024-06-24 09:21:19 ET More on Altimmune Altimmune: Going All-In On Pemvidutide Altimmune: A Potential Minor Player In The Massive GLP-1 Space Altimmune's Pemvidutide Is Not To Be Dismissed Altimmune Q1 2024 Earnings Preview Altimmune falls after Q4 r...